Amyris reports $25.68 million net loss for January

By Sarah Lizee

Olympia, Wash., April 8 – Amyris, Inc. reported a $25.68 million net loss for January on $2.35 million of gross income/sales, according to a monthly operating report filed Friday with the U.S. Bankruptcy Court for the District of Delaware.

To compare, the company reported a $67.16 million net loss for December on $3.42 million of gross income/sales.

The cash balance at the end of January was $20.54 million, up from $17.12 million at the end of December.

Emeryville, Calif.-based Amyris is a synthetic biotechnology company. The company filed bankruptcy on Aug. 9, 2023 under Chapter 11 case number 23-11131.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.